TerminatedPHASE1, PHASE2NCT01610570

Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma

Studying Bone sarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cancer Institute (NCI)
Principal Investigator
Brigitte C Widemann, M.D., MD
National Cancer Institute (NCI)
Intervention
Mithramycin(drug)
Enrollment
8 enrolled
Eligibility
1 years · All sexes
Timeline
2012 – 2014

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01610570 on ClinicalTrials.gov

Other trials for Bone sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Bone sarcoma →

← Back to all trials